Search Results - Erqi Pollom, MD

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes by Surbhi Singhal, MD, Caressa Hui, MD, Joel W. Neal, MD, PhD, Seema Nagpal, MD, Mohana Roy, MD, Millie Das, MD, Kavitha Ramchandran, MD, Erqi Pollom, MD, Giovanni Selvaggi, MD, Heather A. Wakelee, MD, Nathaniel J. Myall, MD

Get full text

SUPPORT: SUrvey of Parental Leave POlicies of RadiaTion Oncology Programs and Residency Applicants by Claire C. Baniel, MD, Vera Qu, BS, Sara Beltrán Ponce, MD, Kekoa Taparra, MD, PhD, Beth Beadle, MD, PhD, Adam Currey, MD, Katie E. Lichter, MD, MPH, Jessica Frank, BS, Hilary Bagshaw, MD, Scott Soltys, MD, Erqi Pollom, MD

Get full text